| Literature DB >> 30987210 |
Roberto B Sousa1, Keila S C Lima2, Caleb G M Santos3, Tanos C C França4,5, Eugenie Nepovimova6, Kamil Kuca7, Marcos R Dornelas8, Antonio L S Lima9.
Abstract
We report for the first time the efficient use of accelerated solvent extraction (ASE) for extraction ofEntities:
Keywords: CBRN defense; MALDI-TOF MS; biological weapons; chemical weapons; ricin
Mesh:
Substances:
Year: 2019 PMID: 30987210 PMCID: PMC6520692 DOI: 10.3390/toxins11040201
Source DB: PubMed Journal: Toxins (Basel) ISSN: 2072-6651 Impact factor: 4.546
Figure 1MALDI-TOF MS spectra of the non-irradiated ricin sample (0 kGy) and the samples irradiated at 10, 20 and 30 kGy.
Ratio signal to noise (S/N) of ricin in the samples for each irradiation dosage (average values, three repetitions).
| Irradiation Dosage (kGy) | Intensity Signal/Noise (S/N) | (S/N of Sample)/ |
|---|---|---|
| 0 | 18.1 | 100.00 |
| 10 | 6.2 | 34.12 |
| 20 | 1.5 | 8.19 |
| 30 | 0.5 | 2.53 |
Figure 2SDS-PAGE gel of samples irradiated at 0, 10, 20 and 30 kGy. M = marker. The bands of interest were identified with numbers 1 and 2. They were removed from the gel and identified by MALDI-TOF/MS..
Figure 3MALDI-TOF MS mass spectra of band 1 (RTA) of the ricin samples. (A) Non-irradiated and (B) irradiated with 30 kGy.
Ricin peptides identified by MALDI-TOF MS in the band 1 of the non-irradiated sample.
| Peptides | Positions | Amino Acids Sequence | [M + H]+ Theoretical | |
|---|---|---|---|---|
| A1 + A2 | 1–26 | IFPKQYPIINFTTAGATVQSYTNFIR | 2990.577 | 2990.6 |
| A6 | 40–48 | HEIPVLPNR | 1074.605 | 1074.3 |
| A7 + A8 | 49–85 | VGLPINQRFILVELSNHAELSVTLALDVTNAYVVGYR | 4084.222 | 2042.4 a |
| A9 | 86–114 | AGNSAYFFHPDNQEDAEAITHLFTDVQNR | 3307.504 | 3306.8 |
| 1654.4 a | ||||
| A10 | 115–125 | YTFAFGGNYDR | 1310.580 | 1310.3 |
| A11 | 126–134 | LEQLAGNLR | 1013.574 | 1013.3 |
| A10 + A11 | 115–134 | YTFAFGGNYDRLEQLAGNLR | 2305.136 | 2304.6 |
| A12 | 135–166 | ENIELGNGPLEEAISALYYYSTGGTQLPTLAR | 3440.722 | 3440.9 |
| A13 | 167–180 | SFIICIQMISEAAR | 1652.849 b | 1653.9 |
| A13 + A14 | 167–189 | SFIICIQMISEAARFQYIEGEMR | 2806.370 b | 2806.6 |
| A14 | 181–189 | FQYIEGEMR | 1172.540 | 1172.3 |
| A14 | 181–189 | FQYIEGEMR | 1188.535 c | 1188.2 |
| A16 + A17 | 192–196 | IRYNR | 721.410 | 721.9 |
| A16 + A17 + A18 | 192–197 | IRYNRR | 877.512 | 876.8 |
| A19 | 198–213 | SAPDPSVITLENSWGR | 1728.855 | 1728.4 |
| A20 | 214–234 | LSTAIQESNQGAFASPIQLQR | 2259.173 | 2258.7 |
| A23 | 240–258 | FSVYDVSILIPIIALMVYR | 2228.240 c | 2228.5 |
a Value corresponding to the double protonated ion. b Considering the formation of the polyacrylamide adduct; c Considering oxidation of methionine to methionine sulfoxide.
Comparison between the amino acid sequences of RTA and RCA120 between positions 85 and 126 *.
| Protein | Amino Acid Sequences between Positions 85 and 126 of Chain A for Ricin and RCA120 |
|---|---|
| Ricin |
|
| RCA120 |
|
* Different amino acids in both sequences are underlined. The digestion with trypsin leads to peptides A9 (in red) and A10 (in blue) in ricin but keeps RCA120 as a single peptide (in green).
Figure 4MALDI-TOF MS mass spectra obtained for band 2 of the SDS-PAGE gel of the ricin samples. (A) Non-irradiated and (B) irradiated with 30 kGy. Magnification of the mass spectra in the region of peptides B1 and B6 is shown in the spectra of the non-irradiated sample.
Peptides identified by MALDI-TOF MS in band 2 of the non-irradiated sample.
| Peptides | Positions | Amino Acids Sequence | [M + H]+ Theoretical | |
|---|---|---|---|---|
| A1 + A2 | 1–26 | IFPKQYPIINFTTAGATVQSYTNFIR | 2990.577 | 2991.5 |
| A16 + A17 + A18 | 192–197 | IRYNRR | 877.512 | 877.2 |
| A6 | 40–48 | HEIPVLPNR | 1074.605 | 1074.7 |
| A7 + A8 | 49–85 | VGLPINQRFILVELSNHAELSVTLALDVTNAYVVGYR | 4084.222 | 2043.0 |
| A9 | 86–114 | AGNSAYFFHPDNQEDAEAITHLFTDVQNR | 3307.504 | 3307.7 |
| A10 | 115–125 | YTFAFGGNYDR | 1310.580 | 1310.7 |
| A11 | 126–134 | LEQLAGNLR | 1013.574 | 1013.6 |
| A14 | 181–189 | FQYIEGEMR | 1172.540 | 1172.6 |
| A19 | 198–213 | SAPDPSVITLENSWGR | 1728.855 | 1728.9 |
| A20 | 214–234 | LSTAIQESNQGAFASPIQLQR | 2259.173 | 2259.3 |
| A23 | 240–258 | FSVYDVSILIPIIALMVYR | 2228.240 a | 2229.1 |
| B1 | 1–12 | ADVCMDPEPIVR | 1415.666 | 1415.8 |
| B6 | 41–52 | SNTDANQLWTLK | 1390.696 | 1390.8 |
| B6 + B7 | 41–53 | SNTDANQLWTLKR | 1546.797 | 1546.8 |
| B13 | 169–182 | AEQQWALYADGSIRPQQNR | 2231.095 | 2230.9 |
| B15 + B16 + B17 | ETVVKILSCGPASSGQRWMF K | 2395.226 | 2396.1 | |
| B17 + B18 + B19 | 216–243 | WMFKNDGTILNLYSGLVLDVRASDPSLK | 3152.645 | 3153.1 |
| B6 * | RCA120 | SNTDWNQLWTLR | 1533.744 | 1533.8 |
| B18 * | NDGTILNLYNGLVLDVR | 1889.013 | 1889.1 |
a Considering the oxidation of methionine to methionine sulfoxide. * Peptide of RCA120.
Figure 5MALDI-TOF MS/MS spectra corresponding to the fragments of precursor ion m/z 1310 (A). Analysis of the MALDI-TOF MS/MS spectra of the precursor ion m/z 1310 (B).
Fragments of peptide A10 identified by MALDI-TOF MS/MS.
| Ions | Amino Acid Sequences | ||
|---|---|---|---|
| precursor | YTFAFGGNYDR | 1310.580 | 1310.4 |
| b2 | YT | 265.118 | 265.0 |
| b3 | YTF | 412.187 | 412.0 |
| b4 | YTFA | 483.224 | 483.2 |
| y1 | R | 175.119 | 175.0 |
| y2 | DR | 290.146 | 290.0 |
| y3 | YDR | 453.209 | 453.0 |
| y4 | NYDR | 567.252 | 567.1 |
| y5 | GNYDR | 624.274 | 623.9 |
| y6 | GGNYDR | 681.295 | 680.8 |
| y7 | FGGNYDR | 828.363 | 828.1 |
| y8 | AFGGNYDR | 899.401 | 899.2 |
| y9 | FAFGGNYDR | 1046.469 | 1046.2 |
Figure 6MALDI-TOF MS/MS spectra corresponding to the precursor ion m/z 3307 (A). Analysis of the MALDI-TOF MS/MS spectrum of the precursor ion m/z 3307 (B).
Fragments of peptide A9 (AGNSAYFFHPDNQEDAEAITHLFTDVQNR) identified by MALDI-TOF MS/MS.
| Ions | Corresponding Amino Acids Sequence | ||
|---|---|---|---|
| precursor | AGNSAYFFHPDNQEDAEAITHLFTDVQNR | 3307.504 | 3307.4 |
| b3 | AGN | 243.109 | 243.1 |
| b4 | AGNS | 330.141 | 329.7 |
| b7 | AGNSAYF | 711.310 | 711.3 |
| b9 | AGNSAYFFH | 995.437 | 995.2 |
| b12 | AGNSAYFFHPDN | 1321.560 | 1321.7 |
| b15 | AGNSAYFFHPDNQED | 1693.688 | 1693.8 |
| b23 | AGNSAYFFHPDNQEDAEAITHLF | 2576.148 | 2576.6 |
| b25 | AGNSAYFFHPDNQEDAEAITHLFTD | 2792.222 | 2792.1 |
| y1 | R | 175.119 | 175.5 |
| y3 | QNR | 417.220 | 417.1 |
| y4 | VQNR | 516.289 | 515.8 |
| y5 | DVQNR | 631.316 | 631.0 |
| y6 | TDVQNR | 732.363 | 732.0 |
| y7 | FTDVQNR | 879.432 | 879.1 |
| y8 | LFTDVQNR | 992.516 | 992.7 |
| y9 | HLFTDVQNR | 1129.575 | 1129.4 |
| y11 | ITHLFTDVQNR | 1343.707 | 1343.5 |
| y12 | AITHLFTDVQNR | 1414,744 | 1415.0 |
| y13 | EAITHLFTDVQNR | 1543.786 | 1544.1 |
| y14 | AEAITHLFTDVQNR | 1614.823 | 1614.8 |
| y15 | DAEAITHLFTDVQNR | 1729.850 | 1730.0 |
| y16 | EDAEAITHLFTDVQNR | 1858.893 | 1858.7 |
| y17 | QEDAEAITHLFTDVQNR | 1986.952 | 1987.0 |
| y18 | NQEDAEAITHLFTDVQNR | 2100.994 | 2100.4 |
| y20 | PDNQEDAEAITHLFTDVQNR | 2313.074 | 2313.5 |
| y21 | HPDNQEDAEAITHLFTDVQNR | 2450.133 | 2450.3 |
| y22 | FHPDNQEDAEAITHLFTDVQNR | 2597.202 | 2597.5 |
| y25 | AYFFHPDNQEDAEAITHLFTDVQNR | 2978.370 | 2978.2 |
| y26 | SAYFFHPDNQEDAEAITHLFTDVQNR | 3065.402 | 3065.6 |
Figure 7MALDI-TOF MS/MS spectrum corresponding to the fragments of the precursor ion m/z 2231. (A) Analysis of the MALDI-TOF MS/MS spectrum of the precursor ion m/z 2231 (B).
Fragments of peptide B13 (AEQQWALYADGSIRPQQNR) identified by MALDI-TOF MS/MS.
| Ions | Corresponding Amino Acids Sequence | ||
|---|---|---|---|
| precursor | AEQQWALYADGSIRPQQNR | 2231.095 | 2231.0 |
| b3 | AEQ | 329.146 | 328.8 |
| b4 | AEQQ | 457.204 | 457.0 |
| b6 | AEQQWA | 714.321 | 714.4 |
| b14 | AEQQWALYADGSIR | 1589.771 | 1589.7 |
| b18 | AEQQWALYADGSIRPQQN | 2056.984 | 2057.3 |
| y1 | R | 175.119 | 175.0 |
| y5 | PQQNR | 642.332 | 642.3 |
| y9 | GSIRPQQNR | 1055.570 | 1055.3 |
| y14 | ALYADGSIRPQQNR | 1588.819 | 1588.9 |
Figure 8Verification of the toxic activity of ricin by MALDI-TOF MS. (a) Control at 0 h; (b) Sample 0 kGy at 0 h (c) Sample 30 kGy at 0 h; (d) Control after 4 h; (e) Sample 0 kGy after 4 h (f) Sample 30 kGy after 4 h; (g) Control after 24 h; (h) Sample 0 kGy after 24 h (i) Sample 30 kGy after 24 h.
Figure 9Scheme of preparation and analysis of the ricin samples.
Time needed for each sample.
| Irradiation Dosage Absorbed | Exposure Time |
|---|---|
| 10 kGy | 8 h 20 min |
| 20 kGy | 16 h 40 min |
| 30 kGy | 25 h 00 min |
Expected peptides from the total proteolysis of ricin with trypsin.
| Abbreviation | Position | Sequence of Amino Acids | Molecular Mass (M) |
|---|---|---|---|
| A1 | 36–39 | IFPK | 504.3 |
| A2 | 40–61 | QYPIINFTTAGATVQSYTNFIR | 2504.3 |
| A3 | 62–64 | AVR | 344.2 |
| A4 | 65–66 | GR | 231.1 |
| A5 | 67–74 | LTTGADVR | 831.4 |
| A6 | 75–83 | HEIPVLPNR | 1073.6 |
| A7 | 84–91 | VGLPINQR | 895.5 |
| A8 | 92–120 | FILVELSNHAELSVTLALDVTNAYVVGYR | 3205.7 |
| A9 | 121–149 | AGNSAYFFHPDNQEDAEAITHLFTDVQNR | 3306.5 |
| A10 | 150–160 | YTFAFGGNYDR | 1309.6 |
| A11 | 161–169 | LEQLAGNLR | 1012.6 |
| A12 | 170–201 | ENIELGNGPLEEAISALYYYSTGGTQLPTLAR | 3439.7 |
| A13 | 202–215 | SFIICIQMISEAAR | 1580.8 |
| A14 | 216–224 | FQYIEGEMR | 1171.5 |
| A15 | 225–226 | TR | 275.2 |
| A16 | 227–228 | IR | 287.2 |
| A17 | 229–231 | YNR | 451.2 |
| A18 | 232–232 | R | 174.1 |
| A19 | 233–248 | SAPDPSVITLENSWGR | 1727.9 |
| A20 | 249–269 | LSTAIQESNQGAFASPIQLQR | 2258.2 |
| A21 | 270–270 | R | 174.1 |
| A22 | 271–274 | NGSK | 404.2 |
| A23 | 275–293 | FSVYDVSILIPIIALMVYR | 2211.2 |
| A24 | 294–302 | CAPPPSSQF | 932.4 |
| B1 | 315–326 | ADVCMDPEPIVR | 1343.6 |
| B2 | 327–330 | IVGR | 443.3 |
| B3 | 331–338 | NGLCVDVR | 874.4 |
| B4 | 339–341 | DGR | 346.2 |
| B5 | 342–354 | FHNGNAIQLWPCK | 1526.8 |
| B6 | 355–366 | SNTDANQLWTLK | 1389.7 |
| B7 | 367–367 | R | 174.1 |
| B8 | 368–372 | DNTIR | 617.3 |
| B9 | 373–376 | SNGK | 404.2 |
| B10 | 373–376 | CLTTYGYSPGVYVMIYDCNTAATDATR | 2948.3 |
| B11 | 404–416 | WQIWDNGTIINPR | 1611.8 |
| B12 | 417–482 | SSLVLAATSGNSGTTLTVQTNIYAVSQGWLPTNNTQPFVTTIVGLYGLCLQANSGQVWIEDCSSEK | 6932.4 |
| B13 | 417–482 | AEQQWALYADGSIRPQQNR | 2230.1 |
| B14 | 502–512 | DNCLTSDSNIR | 1236.5 |
| B15 | 513–517 | ETVVK | 574.3 |
| B16 | 518–529 | ILSCGPASSGQR | 1174.6 |
| B17 | 530–533 | WMFK | 610.3 |
| B18 | 534–550 | NDGTILNLYSGLVLDVR | 1861.0 |
| B19 | 551–557 | ASDPSLK | 716.4 |
| B20 | 558–576 | QIILYPLHGDPNQIWLPLF | 2276.2 |